VASCULAR ULCERS TREATMENT MARKET ANALYSIS

Vascular Ulcers Treatment Market, By Disease Type (Arterial Ulcers, Venous Ulcers, Neurotropic Ulcers, Diabetic Ulcers, and Others), By Drug Class (Antibiotics, Hemorrheologic Agents, Corticosteroids, Non-steroidal Anti-inflammatory Drug, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028

Published In : Sep 2021
Code : CMI4639
Pages :167
Formats :
Excel and PDF
Industry : Pharmaceutical

Vascular Ulcers Treatment MarketSize and Trends

Vascular Ulcers Treatment Market Report Coverage

The global vascular ulcers treatment market is estimated to be valued at US$ 3.36 Bn in 2021 and is expected to exhibit a CAGR of 6.1 % over the forecast period (2021-2028).

The emerging prevalence of diabetes, one of the main causes of vascular ulcers, is expected to bolster the growth of global vascular ulcers treatment market. For instance, according to the Centers for Disease Control and Prevention Report 2020, diabetes affected 34.2 million people in 2020. Diabetes was diagnosed in 26.9 million people of all ages or 8.2 percent of the U.S. population, with 7.3 million people or 21.4 percent, remaining undiagnosed.

Figure 1: Global Vascular Ulcers Treatment Market Share (%) Analysis, By Drug Class, 2021